accountNov. 23 (Bloomberg) -- King Pharmaceuticals Inc., LifePoint Hospitals Inc. and Endo Pharmaceuticals Holdings Inc.
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
KING PHARMACEUTICALS (KG)
King Pharmaceuticals, Inc. is the world’s 39th-largest pharmaceutical company. It provides branded prescription pharmaceutical products worldwide It primarily offers branded prescription products for primary care physicians, neurologists, orthopedic surgeons, hospitals, internal medicine physicians, allergists, pediatricians, and pain specialists. Some brands include Altace for heart attack prevention; Levoxyl for hypothyroidism; Sonata for sleeping; and Skelaxin, a muscle relaxant.
King Pharmaceuticals (KG) is part of Business Exchange, suggested by
Ginny Moore.
This topic contains
196 news
and
136 blog
items.
Read updated news, blogs, and resources about King Pharmaceuticals (KG). Find user-submitted articles and reactions on King Pharmaceuticals (KG) from
like-minded professionals.
Blogs
Recent blog posts on this topic.
Nov. 23 (Bloomberg) -- King Pharmaceuticals Inc., LifePoint Hospitals Inc. and Endo Pharmaceuticals Holdings Inc.
...of Saskatchewan, King Pharmaceuticals Inc...
The major indexes fell for the second day in a row, with the Dow closing down 0.9%, the S&P 500 falling 1.
King Pharmaceuticals Inc. (NYSE: KG) - hit $11.88. May be benefitting from mixed...
King Pharmaceuticals (NYSE: KG) hit a new 52-Week high of $11.91 so far today.
Anyone know any recruiters who work with King?
Options Update: King Pharmaceuticals, Inc. (KG) and Headwaters Corp. (HW)
National Insurance, Sells Methanex Corp., King Pharmaceuticals Inc...
BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) today announced plans...
King Pharmaceuticals (NYSE: KG) opened at $10.30. So far today, the stock has hit a low of $10.30 and a high of $10.70.
King Pharmaceuticals, Inc is scheduled to report its fiscal third quarter 2009 financial results on Thursday, November...
NEW YORK (MarketWatch) -- King Pharmaceuticals Inc.
On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development,...
King Pharmaceuticals (KG) is expected to report Q3 earnings Thursday, November 5 before market open, with a conference...
Plaintiff: King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc, King Pharmaceuticals Research and Development, Inc.
...com/Summary-Company-Profile/king-pharma...
BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE:KG) announced today that...
...its website a warning letter send to King Pharmaceuticals over two Embeda video news releases. The letter is below.
WASHINGTON, Oct 20 (Reuters) - Two video news releases for King Pharmaceuticals' (KG.N) pain drug Embeda left out a...
Top Sources: King Pharmaceuticals (KG)
- Finance, Investments n Trading
- BlogNetNews.com » Tennessee
- M2 PressWIRE: Latest Headlines
- MarketIntelligenceCenter.com
- optionMONSTER News
- BioSpace.com Featured News
- Analysen Ticker - www.finanzen.net
- Bespoke Investment Group
- BIOBUSINESS Financial Focus news from GEN
- BIOBUSINESS Inside Industry news from GEN
Most Active Users in this Topic
No user contributions
